Waters Opens Food and Water Centre in Singapore
Waters Corporation has opened a new International Food and Water Research Centre (IFWRC) in Singapore to address the growing challenges of food and water security and safety.
Waters Corporation (Milford, Massachusetts, USA) has opened a new International Food and Water Research Centre (IFWRC) in Singapore to address the growing challenges of food and water security and safety. The centre will be led by a Scientific Advisory Panel that will identify meaningful, innovative projects by working with academic and industrial leaders.
“In past decades, Singapore has become a major hub for food and water research that has far-reaching impacts around the globe. The country has long had well-established academic laboratories where scientists have done significant work,” said Mike Harrington, Senior Vice President of Global Markets at Waters
“Based on that, along with Waters’ storied history in Singapore, we are thrilled to open the IFWRC, a model for scientific collaboration between industry, government, and academia that will ultimately drive significant advances in food and water quality,” continued Harrington.
Important research areas such as food fraud discovery, water contamination research, food quality enhancement, and new ingredient and formulation studies will be prioritized as the research centre seeks to find solutions to food and water supply challenges around the world.
Researchers will gain access to IFWRC’s state-of-the-art facilities outfitted with analytical instrumentation from Waters. In addition, the laboratory will be staffed with scientists and researchers who will work closely with project owners throughout implementation.
For more information, please visit www.waters.com
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
